French biomed incubator Clinatec raises €10m

French biomedical research center Clinatec said today that it has raised $10.6 million (€10 million) to support research for diagnosis and treatment of neurodegenerative diseases, cancer and motor disabilities. The Grenoble-based incubator said that the campaign began in October 2015, led by a founding donor, the Edmond Safra Foundation, which pledged to match up to €5 million in donations. Clinatec is led by CEO Alim-Louis Benabid, a neurosurgeon and a biophysics professor at Université Joseph Fourier in Grenoble. Clinatec also highlighted upcoming clinical developments, including an implant that captures electrical signals from the brain while a computer decodes and transcribes the data to an exoskeleton. The 1st patient for the Brain-Computer Interface project has received an implant and analysis of the therapy is underway. A 2nd implantation is planned for 2017. The company also provided an update for the Near InfraRed project, which is evaluating the neuroprotective effect of near-infrared light to slow the disease progression of Parkinson’s and other neurological diseases. Using an intracranial medical device, therapeutic light is delivered to precise spots in the brain. Clinatec said it will launch a clinical trial to confirm preclinical data next year. The Epicool project is an effort to develop an implantable cooling system to block seizures, since applying cold in the brain is known to reversibly block neuron activity. The research center is planning a c...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Funding Roundup Implants Neurological Neuromodulation/Neurostimulation Clinatec Source Type: news